Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 908 results found. Search for [ vaccine updates ]

Results 1 to 21 of 908
BusinessToday.In
November 23, 2020
India Stock Market Highlights Today: IndusInd Bank, followed by Bajaj Finserv, Bajaj Finance, Reliance Industries, ONGC, NTPC and Tata Steelwere among the top gainerz in the Sensex pack. On the other hand, HDFC, Asian Paints, ITC and Bharti Airtel were among the laggards


BusinessToday.In
November 22, 2020
Share market this week: The Indian benchmark indices may see volatility this week as traders will adjust their F&O positions ahead of November series contracts expiry due on November 26


BusinessToday.In
November 21, 2020
Pfizer's CEO Albert Bourla confirmed the company's application and said in a video statement,  'It is with great pride and joy - and even a little relief - that I can say that our request for emergency use authorization for our COVID-19 vaccine is now in the FDA's hands.'


BusinessToday.In
New Delhi, November 21, 2020
COVID 19-driven reforms can raise India's medium-term growth; US President-elect Joe Biden has said he wants to make sure that China plays by the rules and announced that his administration will rejoin the World Health Organisation; Pfizer approaches USFDA to secure emergency use authorisation for COVID vaccine. Watch this and more news on News Blast.


Shailendra Shukla
New Delhi, November 21, 2020
WHO removes Remdesivir from list of COVID-19 medicines The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients. \"The suspension is a signal to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for Covi...


BusinessToday.In
November 20, 2020
The dollar index fell by 0.02% to 92.28 against the basket of other Asian currencies, following news that US lawmakers may restart negotiations on economic stimulus


BusinessToday.In
November 20, 2020
India Stock Highlights Updates Today: Bajaj Finserv followed by Tata Steel, Titan, Bajaj Finance, HDFC twins and Kotak Bank were among the top gainers on Sensex pack. On the other hand, ICICI Bank, ONGC, Axis Bank, SBI and IndusInd Bank were among the laggards


BusinessToday.In
November 20, 2020
Adar Poonawalla said if things go according to the plan, the coronavirus vaccine will be available for vulnerable populations by January or February. And, in March or April, the vaccine will enter the market for the general public


BusinessToday.In
November 20, 2020
Stocks to watch today on November 20: RIL, Gland Pharma, SBI, Alkem Labs, Bharti Infratel, Wipro, Infosys among others are the top stocks to watch out for in Friday's trading session


Rajeev Dubey
November 20, 2020
Emboldened, firms indulge in a game of one-upmanship based on alarmingly low number of trials. Sputnik had been tried on only 20 patients before Gamaleya made the claim; Pfizer 120 and Moderna 95


BusinessToday.In
November 19, 2020
Reversing the trend after 10 days of consecutive gains, YES Bank share price today opened at Rs 14.57 today and later rose to the day's high of Rs 14.69 on BSE. However, the stock also hit the day's low of Rs 14.45, falling 1.5% against the earlier close of Rs 14.68


BusinessToday.In
November 19, 2020
The domestic unit opened at 74.28 per US dollar at the interbank forex market and gained ground and touched 74.23. In volatile trade, the local unit also fell by 13 paise to 74.32 per dollar over its previous close


BusinessToday.In
November 19, 2020
Pfizer stock opened with a gain of 6.73% at Rs 5240 on BSE


BusinessToday.In
November 19, 2020
India Stock Market Highlights Today: Infosys, HCL Tech, SBI, Airtel, HUL were among the top losers today, while Bajaj twins, Tata Steel, Titan, ONGC, M&M, NTPC were among the top gainers on Sensex pack 


BusinessToday.In
November 19, 2020
Stocks to watch today on November 19: Pfizer, ACC, Wipro, Vedanta, IndiGo, SpiceJet, TCS among others are the top stocks to watch out for in Thursday's trading session


Manoj Sharma
November 18, 2020
Pfizer says Phase 3 study of their COVID-19 vaccine candidate met \"all primary efficacy endpoints\".  During its early analysis, vaccine had shown 90 per cent efficacy but final analysis involving 170 confirmed cases of COVID-19 showed 95 per cent efficacy


Shailendra Shukla
New Delhi, November 18, 2020
Indian students pumped $7.6 billion to US economy in 2019-20 Indian students contributed USD 7.6 billion to the US economy in the academic year 2019-20, even though there was a 4.4 per cent drop in the total number of Indian students, according to a report. China remained the largest source of international students in the US, with the number of Chinese students in the country increasing for the 16th consecutive year. India remained the second largest source of international students, despi...


BusinessToday.In
November 18, 2020
India Stock Market Highlights Today: Sensex closed 227 points higher at 44,180 and Nifty ended 64 points higher at 12,938. Shares of M&M , L&T and IndusInd  Bank were the top Sensex gainers rising up to 10.76%


BusinessToday.In
New Delhi, November 17, 2020
Moderna announced on Monday that its experimental COVID-19 vaccine 'mRNA-1273' was 94.5 per cent effective in preventing coronavirus. The statement was issued on the basis of interim data from a late-stage clinical trial. The announcement makes Moderna the second US-based pharmaceutical giant to have reported exceedingly hopeful results from clinical trials of their respective coronavirus vaccine candidates, after Pfizer vaccine. Watch the video for more.


BusinessToday.In
November 17, 2020
These early efficacy figures don't tell the whole story. The data results are based on a relatively smaller group of participants who received these vaccine shots. The actual efficacy could be known only after the final results are out as Phase 3 clinical trials end


PAGES 1 OF 46  12345